You are now leaving Kedrion Corporate site. Medical information including licensed uses may be different outside of the EU countries.
NO
YES

HIGHLIGHTS

CORPORATE

Hemophilia seen through children's eyes: Kedrion teams up with LA Kelley

Three books of the series My First Factor Creation are now available for free download

read more 

CORPORATE

SIPPET study results published in the “New England Journal of Medicine”

This investigator-initiated clinical study involved 42 hemophilia treatment centers from all over the world

read more 

CORPORATE

CURhE, Global Alliance for mother and child healthcare

Kedrion among the founding members. The aim is Rh disease eradication

read more 
  1. CORPORATE - 18-01-2016

    A brand new location for KEDPlasma donors in the very center of Fürth

    Plasma collected is turned into life-saving therapies to serve patients in Germany and worldwide

    read more 
  2. CORPORATE - 08-01-2016

    KEDPlasma acquires two plasma centers from ImmunoTek LLC in the US

    The acquisition is part of a five-year growth plan of supplying highest-quality plasma to Kedrion Biopharma

    read more 
  3. EVENTS - 07-12-2015

    Hemophilia A. SIPPET study selected by the American Society of Hematology

    Presented at the ASH Congress in Orlando, it was chosen from amongst approximately three thousand studies

    read more 
  4. CORPORATE - 13-07-2015

    Humanitarian programme to reduce the gap in the access to clotting factors

    Kedrion helps the WISH project come true: Italian CNS and the World Federation of Hemophilia sign agreement in London

    read more 

Pages

For more information please contact: pressoffice@kedrion.com